Efficacy of Estrogen cream for treatment of Vaginal Atrophic in Postmenopausal women at Sunpasitthiprasong Hospital

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190309004

Enrollment

Unknown

Registered

2019-03-09

Start date

2018-08-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal Atrophic in Postmenopausal women at Sunpasitthiprasong Hospital Menopause Vaginal Atrophy Vaginal maturation index (VMI) Vaginal pH The most bothersome vaginal score

Interventions

Efficacy of Estrogen cream for treatment of Vaginal Atrophic in Postmenopausal women at Sunpasitthiprasong Hospital,compare efficacy of Estrogen cream and placebo for treatment of

Placebo Comparator Drug,Placebo Comparator Drug

conjugated estrogen 0.625 mg/tab ,cream base

Eligibility

Sex/Gender

Female

Age

45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Healthy Menopausal women or Bilateral oophorectomy with or without hysterectomy more than 6 weeks

Exclusion criteria

Exclusion criteria: history of malignancy cardiovascular diseses history of estrogen androgen or progestin used within 3 months history of abnormal uterine bleeding,unknown cause

Design outcomes

Primary

Measure	Time frame
Vaginal maturation index end of 12 weeks vaginal in menopausal women	—

Secondary

Measure	Time frame
Vaginal pH , The most bothersome vaginal score , Endometrium thickening end of 12 weeks vaginal in menopausal women	—

Countries

thailand

Contacts

Public Contactfongfon phonjan

ministry of public health

fongfonft@gmail.com0873753301

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026